Back to Academy

Everything to Know About GxP Compliance in 2026

Businesses in heavily regulated industries such as pharmaceuticals and MedTech treat good practice (GxP) as the cornerstone of their daily operations. GxP standards are used as references throughout the entire product lifecycle.

This guide to GxP compliance explains what the term means, why it matters for pharma and MedTech organisations, and what steps to take when preparing your own processes for compliance.

In short

  • What is it? GxP compliance is adherence to a set of "Good Practice" (GxP) regulations and guidelines, such as GMP, GDP, GLP and GCP, that govern how pharmaceutical, biotech and medical device products are developed, manufactured, tested and distributed. Their purpose is to ensure products are safe, effective and consistently produced to quality standards.
  • Insights from 2026 and beyond: Regulators are working toward greater international harmonisation, notably through ICH guidelines such as ICH E6 (R3) for good clinical practice. This helps reduce duplicated compliance work for companies operating across several markets, although the FDA framework remains the benchmark many organisations check against first.
  • How it is used in clinical trials: GxP requirements, particularly GCP, govern how clinical trial data is captured, validated and stored. They call for audit trails, electronic signatures and validated systems throughout the trial lifecycle.
  • Who is Ledidi? Ledidi is a Norwegian software company founded by academic surgeons and software engineers. We provide a unified, secure cloud platform, comprising Ledidi Core, Ledidi Trials and Ledidi Registries, that combines data capture, real-time analytics and global collaboration.

What is GxP compliance?

GxP compliance is a broad term for the regulations and guidelines that govern different types of pharmaceutical operations. It stands for "Good x Practice", where the "x" stands for the field in question.

Examples of GxP frameworks

  • Good manufacturing practice (GMP)
  • Good distribution practice (GDP)
  • Good laboratory practice (GLP)
  • Good clinical practice (GCP)
  • Good storage practice (GSP)

GxP compliance: history and today

GxP concepts first took shape in the US, where the FDA introduced the first Good Manufacturing Practice and Good Laboratory Practice rules. They exist to ensure that businesses in pharmaceuticals, clinical research and biotechnology make products that are safe for patients to use. Today, regulators worldwide define and apply their own versions.

Each country has its own regulator, but the guidelines are broadly similar from country to country. FDA requirements are widely treated as the benchmark, partly because the US is the world's largest pharmaceutical market. In Europe, the European Medicines Agency (EMA) and, in the UK, the Medicines and Healthcare products Regulatory Agency (MHRA) also define and refer to GxP in their publications.

Today, GxP guidelines provide a framework for maintaining compliance, controlling risk and ensuring the integrity of pharmaceutical processes throughout their lifecycle.

Also read: What to know about CDMS software for your clinical trials in 2026

GxP compliance in pharma and MedTech: what you should know

In the pharmaceutical industry, adhering to regulatory standards and guidelines is critical to ensure the safety, quality and efficacy of everyday practice. GxP compliance matters for several reasons:

Ensuring patient safety

Pharmaceutical products are developed, manufactured and distributed to human patients, so quality control measures must be strict and effective. Every product must be safe to use and protect the wellbeing and health of its users.

Upholding product quality

The entire supply chain must follow standards that minimise the risk of product defects and contamination.

Maintaining regulatory compliance

In most countries, compliance is a legal requirement, which makes it non-negotiable for any pharmaceutical business. Failing to comply can lead to regulatory sanctions, fines or even suspension of operations.

Building and maintaining reputation and trust

A company's commitment to quality, safety and integrity builds trust and is a cornerstone of a good reputation among regulators, healthcare professionals and patients.

GxP compliance in MedTech: what is different?

The core principles of GxP compliance apply to both pharmaceutical products and medical devices, but MedTech manufacturers face another layer of regulatory complexity. In addition to GMP-type quality system requirements, usually implemented through ISO 13485, and good clinical practice for device studies (ISO 14155), they must adhere to frameworks such as the EU Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR). If they sell devices on the American market, FDA 21 CFR Part 11 requirements for electronic records and signatures also apply.

MedTech manufacturers also work through a different sequence of clinical investigation stages, which changes the role of compliance before and after market launch. For them, GxP compliance extends into post-market surveillance (PMS) and post-market clinical follow-up (PMCF) studies instead of ending when the product first reaches the market. The same audit trail, data integrity and validated-system standards that apply in a pre-market clinical trial continue for as long as the device is on the market.

Continue reading: clinical investigations in MedTech, and how they differ from pharma clinical trials

GxP compliance in Ledidi Trials

Ledidi Trials is a dedicated, specialised module for GxP-regulated trials. It is built for regulatory clinical trials run by MedTech companies, biotech companies and Contract Research Organisations (CROs), the same audiences GxP guidelines exist to protect.

Ledidi Trials was independently audited and confirmed audit-ready in January 2026 by Thomas Pauly CISA / DHC, verifying compliance with key regulatory expectations, including FDA 21 CFR Part 11, ICH GCP E6 (R3) and ISPE GAMP 5. You can request a copy of the Trials audit report from the Ledidi Trust Centre.

Explore Ledidi Trials

The 5 Ps of GxP

Effective compliance relies on five core elements that work together to maintain control and quality: people, procedures, products, premises and equipment, and processes. To maintain compliance, your organisation must manage and control all five.

  • People: Qualified, trained personnel are the backbone of any organisation, especially in GxP-compliant processes. Each person must clearly understand their responsibilities.
  • Procedures: Standard operating procedures (SOPs) must be consistent across teams and team members, so that tasks are performed the same way every time. Compliance instructions are documented to give each team member a clear, step-by-step roadmap.
  • Products: Protecting the quality and integrity of regulated products is the ultimate goal of GxP.
  • Premises and equipment: The physical environment where products are stored and processes are carried out must be suitable for its purpose.
  • Processes: All processes are defined, validated and consistently carried out.

Which industries are affected by GxP?

When preparing for GxP

Depending on whether you work in pharmaceuticals, clinical research or another industry where GxP applies, start by evaluating which guidelines are relevant to your organisation. From there, plan how to integrate GxP into your existing processes and identify which new mechanisms you need. An essential part of this is to establish clear roles and responsibilities throughout.

Whatever your sector, these are your main activities when integrating GxP into your organisation:

Ensure proper training

All employees must be introduced to the GxP guidelines and receive proper training on what the regulations mean, in both theory and practice. They should also get a well-rounded introduction to the procedures and documentation that are critical for compliance.

Implement quality systems

Quality management systems that cover all GxP areas, including change control, corrective and preventive actions (CAPAs) and internal audits, should be part of daily operations.

Control document management

Document control systems manage and maintain accurate records, including standard operating procedures (SOPs), batch records and validation documents.

Do a risk assessment

A risk assessment is your best tool for mitigating risks to product quality, patient safety and regulatory compliance.

Validate equipment and facilities

Validating equipment and facilities should include computer system validation (CSV) where it applies.

Implement controls

Controls protect the integrity, security and reliability of your systems. They include backup and recovery mechanisms, defined contingency plans, planning for disasters and emergencies, error handling protocols and procedures for corrective measures.

Also read: Guide to eCRFs in clinical trials

Being compliant in 2026 and beyond

The medical technology landscape is going through a major regulatory shift, driven by stricter oversight frameworks such as the EU MDR and IVDR. At the same time, the rapid rise of artificial intelligence (AI) and digital health solutions means manufacturers must handle data-heavy legislation alongside standard medical safety guidelines. Greater digital connectivity has also made cybersecurity and data privacy central pillars of compliance, because networked medical devices are more vulnerable.

Several recent changes show the direction of travel. ICH E6 (R3), the revised international good clinical practice guideline, is being implemented across regions. In the US, the FDA's Quality Management System Regulation (QMSR) has applied since 2 February 2026 and incorporates ISO 13485:2016 by reference. In the EU, the AI Act adds obligations for high-risk AI in medical devices. For compliance teams, this makes validated, audit-ready software an increasingly important part of staying compliant.

Watch: Realise your clinical trial design with us

Staying GxP-compliant across a trial's lifecycle depends on consistent processes, validated systems and clear data governance, not only at the manufacturing stage but throughout data capture and analysis too. With Ledidi, a research group can run a clinical registry on Ledidi Registries and a manufacturer-sponsored, GxP-regulated clinical trial on Ledidi Trials in the same secure environment, without migrating data or retraining staff.

Watch more videos of Ledidi in practice

How Ledidi can benefit your clinical trial design

Ledidi brings EDC, clinical data management and registry capabilities into one connected, validated environment rather than three separate systems, which reduces the number of points where compliance can break down. Study teams design eCRFs themselves with a no-code form builder, so forms can mirror the actual clinical workflow instead of forcing investigators into a generic template that risks data quality problems or protocol deviations.

For MedTech teams running PMCF or other post-market studies, and for pharma or CRO teams that need GxP-regulated trial support, this means faster study start-up, direct ownership of trial data and a platform built to stay inspection-ready throughout the trial lifecycle.

About Ledidi

Ledidi is a Norwegian software company founded in 2016 by two academic surgeons and three software engineers with extensive expertise in system architecture and cloud computing.

Frequently asked questions

What is GxP and non-GxP in pharma?

GxP activities are those directly governed by Good Practice regulations, such as manufacturing, clinical trials and distribution. Non-GxP activities are internal business functions, such as marketing or HR, that are not subject to those specific quality regulations.

What is GxP data in pharma?

GxP data is any data generated or used in a GxP-regulated process, such as clinical trial results, manufacturing batch records or laboratory test results. It must meet data integrity standards, commonly summarised as ALCOA+.

What is GxP, regulatory and compliance?

GxP refers to the Good Practice guidelines themselves. Regulatory refers to the government bodies (FDA, EMA, MHRA) that define and enforce them. Compliance is the state of meeting those requirements.

What does GxP compliance mean?

It means an organisation's people, processes and systems consistently meet the applicable Good Practice standards for its industry, verified through documentation, validation and audit readiness.

Sources

More From Ledidi Academy